Over the course of the COVID-19 pandemic, the healthcare field has been hit hard—facing employment challenges, increased burnouts, and more. Yet salaries have been slow to rise, and conditions haven't improved. Dr. Thuy Nguyen from the University of Michigan School of Public Health joins Dr. Charles Turck to share how employment in the healthcare field has changed over the course of the COVID-19 pandemic.

When we say the words behavior, diet, habits, and environment, chances are you don't think of the body's immune system. But based on recent research, all of those factors play a role in influencing immune function. So how can we keep them in mind and boost our immunity in the face of prevalent diseases, including COVID-19? Find out with Dr. Charles Turck as he speaks with Dr. Heather Moday, author of The Immunotype Breakthrough: Your Personalized Plan to Balance Your Immune System, Optimize Health, and Build Lifelong Resilience.

COVID-19 is still an ongoing public health threat, and the continual emergence of concerning variants has resulted in ongoing hospitalizations. Joining us to review VEKLURY, the first and only FDA-approved treatment for COVID-19 in hospitalized patients, its antiviral mechanism of action, and efficacy and safety results from the ACTT-1 clinical trial, is frontline COVID-19 treater Dr Raj Dasgupta.

Dr Raj Dasgupta is a quadruple board-certified pulmonary and critical care specialist at one of the largest hospitals in Los Angeles, California. He will be joined by Tom Oppelt, Senior Director of Medical Affairs at Gilead Sciences.

COVID-19 has led to several unexpected challenges, impacting several parts of the body, including our patients' voices. What do we need to know about these impacts to better care for our patients? To answer this question, Drs. Amy McGorry and Catherine Crowley of Long Island University in New York join Dr. Charles Turck to share their clinical experience with vocal fatigue and dysphonia related to COVID-19.

The COVID-19 pandemic has taken a toll on all patients, especially pregnant women. Here to walk us through her research on the pandemic's impact on the psychosocial health of mothers and the neurodevelopment of their fetuses is Dr. Dani Dumitriu, a pediatrician, neuroscientist, and pediatric environmental health scientist at Columbia University in New York.

Once a patient is discharged from the hospital after battling COVID-19, the war they face with this disease may not be over. In fact, many patients continue to experience long-term effects, which is why some institutions have formed clinics that are solely dedicated to caring for these patients. To learn more about how one such clinic is helping patients manage these devastating effects, Dr. John Russell speaks to physiatrist Dr. Benjamin Abramoff from the Post-COVID Assessment and Recovery Clinic at Penn Medicine in Philadelphia.

From widespread variants to the threat of a twindemic -- what has the COVID-19 pandemic taught us? And can we learn to coexist with this virus? Dr. Charles Turck is joined by Dr. William Schaffner from the National Foundation for Infectious Diseases to discuss what's on the horizon for the pandemic.

While many people across the country have access to COVID-19 vaccines, there are certain communities where access is not as easy. So what can we do to address the vaccination gaps and barriers to care during the COVID-19 pandemic and beyond? Find out with Dr. Hector Chapa as he speaks with Dr. Linda Bradley from Case Western Reserve University, who shares a brief history of the presence of social determinants of health and racial disparities across our nation and how they impact our current vaccination efforts.

Amid the ongoing COVID-19 pandemic, countries in Sub-Saharan Africa are also facing high rates of HIV and AIDS prevalence. But after the success of the mRNA COVID-19 vaccines, could an mRNA vaccine for HIV/AIDS be on the horizon? Here to explore emerging research and the potential role that mRNA technology might have in battling this global epidemic is Dr. Chris Beyrer, a Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland.

Over 1.5 million viruses could potentially cause a future pandemic. Could antibodies be the key to neutralizing those viruses? Here to share how future vaccination efforts might incorporate neutralizing antibodies and her research on preventing future pandemics is Dr. Jeniffer Hernandez, Associate Professor of Biopharmaceutical Sciences at the Keck Graduate Institute.